Neuro65/AOCN2024

Presentation information

Print

Oral Session

Japanese

[O-12] Oral Session 12 ［Japanese］「Dementia 2」

Thu. May 30, 2024 8:00 AM - 9:00 AM Room3 (Hall B7, B Block, 7F, TIF)

Chair(s): Ryoko Ihara (Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan)

[O-12-1] Efficacy and Safety of Donanemab in Overall and Japanese Patients with Early Symptomatic AD

Shoichiro Sato1, Epelbaum Stephane2, Naohisa Hatakeyama1, Shinji Fujikoshi1, Hideaki Katagiri1 (1.Eli Lilly Japan. K.K., Kobe, Japan, 2.Eli Lilly and Company. Indianapolis, USA)

Abstract password authentication.
You can find the password on page 15 of the program book.

Password